Women's Health News

RSS

3.5 million FC2 Female Condoms ordered for distribution at 2010 World Cup

The Female Health Company announced that it has fulfilled an order for 3.5 million FC2 Female Condoms to be distributed for HIV/AIDS prevention to attendees at the 2010 World Cup. The 2010 World Cup will take place in The Republic of South Africa from June 11, 2010 to July 11, 2010.

2 Jun 2010

Genes influence AIAA side effect in breast cancer survivors

Aromatase inhibitor-associated arthralgia (AIAA) is a major side effect in breast cancer survivors, producing joint pain so severe that as many as ten percent of women discontinue their therapy prematurely while undergoing treatment with these lifesaving drugs.

2 Jun 2010

Targeted monoclonal antibodies show promise for pancreatic and metastatic breast cancer

Early trials using targeted monoclonal antibodies in combination with existing therapies show promise in treating pancreatic cancer and metastatic breast cancer, according to research that will be presented by investigators from the University of Pennsylvania's Abramson Cancer Center at the 2010 meeting of the American Society of Clinical Oncology June 4 through 8.

2 Jun 2010

UT Southwestern researchers compare TVT and TOT sling procedures for stress urinary incontinence

As part of a national clinical trial, UT Southwestern Medical Center researchers found little difference in effectiveness between two popular treatments for one of the most common ailments among American women: stress urinary incontinence.

2 Jun 2010

Naples Diagnostic Imaging Centers to deploy IntelePACS Breast Imaging digital mammography solution

Intelerad® Medical Systems, a leader in medical imaging PACS and workflow solutions, today announced that Naples Diagnostic Imaging Centers will be replacing its current mammography workstations with the IntelePACS® Breast Imaging digital mammography solution.

2 Jun 2010

FDA grants priority review status to Eisai's eribulin NDA

Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted priority review status to the company's New Drug Application (NDA) for the investigational agent eribulin mesylate ("eribulin," also known as E7389). Eisai is seeking FDA approval for eribulin in the treatment of patients with locally advanced or metastatic breast cancer previously treated with at least two chemotherapy regimens, including an anthracycline and a taxane.

2 Jun 2010

Prototype breast cancer vaccine shows promising results in mice

US scientists have developed a prototype breast cancer vaccine that has shown promising results in very early laboratory tests on mice. The vaccine contains a protein called alpha-lactalbumin, which is found in large quantities in the majority of breast cancers.

2 Jun 2010

New report shows one in three young women receive HPV vaccine to prevent cervical cancer

Only about one in three young women has received the human papillomavirus vaccine to help prevent cervical cancer, according to a new report from researchers at Washington University School of Medicine in St. Louis.

2 Jun 2010

Canada willing to spend $1B on G8 maternal, child health initiative

Canada has told other G8 countries that it "is willing to put about $1 billion toward maternal and child health - as long as other countries ante up, too," the Canadian Press/Winnipeg Free Press reports.

2 Jun 2010

Amgen's Prolia receives FDA approval for treatment of postmenopausal women with osteoporosis

Amgen Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Prolia™ (denosumab) for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy. Prolia, the first and only FDA-approved RANK Ligand inhibitor, is an every six month 60 mg subcutaneous injection administered by a health care professional.

2 Jun 2010

FDA approves Prolia for postmenopausal women with osteoporosis

The U.S. Food and Drug Administration approved Prolia, an injectable treatment for postmenopausal women with osteoporosis who are at high risk for fractures.

2 Jun 2010

Paid parental leave in Australia may soon be a reality

Australia’s Liberal opposition has allowed the Rudd government to implement the paid parental leave scheme with effect from 1st January 2011. As per this scheme both parents will get an 18 weeks' paid leave at the minimum wage rate of $543 a week. At present Australia is one of the only two OECD countries that does not have a paid parental scheme.

1 Jun 2010

GE Healthcare introduces new CESM technology to aid in breast cancer diagnosis

GE Healthcare, a pioneer in digital mammography, today announced the introduction of an innovative technology to aid in breast cancer diagnosis. GE Healthcare's new SenoBright Contrast Enhanced Spectral Mammography technology reduces ambiguity in mammography results, enabling physicians to detect and diagnose cancer with more confidence - even in the densest part of the breast tissue more rapidly and accurately.

1 Jun 2010

Hepatitis C investigations intensify as number of women infected by doctor rises

In recent news 12 women had been infected with the Hepatitis C virus allegedly from an anaesthetist Dr James Latham Peters, practising at an abortion clinic, Croydon Day Surgery. As the investigations continue the number of infected women has risen to 44.

1 Jun 2010

Health law mandates higher Medicare payment for osteoporosis tests

The Boston Globe: "A $3 million campaign by doctors, scanner operators, manufacturers, and groups devoted to women's health helped persuade lawmakers to overrule Medicare administrators this year and restore much of the reimbursement for osteoporosis tests. In a little-noticed provision buried deep in the sweeping new health care bill, Congress decreed that Medicare shall pay $97 for each test, instead of $50.

1 Jun 2010

New study finds usage of antidepressants increases risk of miscarriage in pregnant women

A new study in CMAJ (Canadian Medical Association Journal) found a 68% increase in the overall risk of miscarriage in pregnant women using antidepressants.

1 Jun 2010

Women unaware of their heart disease risk: Report

The Australian Institute of Health and Welfare has come up with results of their study funded by the National Heart Foundation that warns Australian women of their heart disease risk. It says that heart disease is the leading killer of Australian women and most women (eight out of ten) think that heart disease kills only “old men”.

31 May 2010

Free educational forum tailored to the needs of people diagnosed with breast cancer

In Canada, it is estimated that 22,700 women will be diagnosed with breast cancer and that an estimated 5,400 women will die from the disease this year.

31 May 2010

European Society of Human Reproduction and Embryology 2010 meeting set for June 27-30 in Rome, Italy

New research findings from fertility experts from Europe, the Americas, Asia & Australasia

31 May 2010

Overall increase of cesarean births not due to maternal request

Fewer than two per cent of cesarean births in British Columbia were a result of maternal request, but the number of cesarean and assisted vaginal deliveries varied widely across health regions in B.C., according to a new study by University of British Columbia researchers.

31 May 2010

Women's Health News

3.5 million FC2 Female Condoms ordered for distribution at 2010 World Cup

Genes influence AIAA side effect in breast cancer survivors

Targeted monoclonal antibodies show promise for pancreatic and metastatic breast cancer

UT Southwestern researchers compare TVT and TOT sling procedures for stress urinary incontinence

Naples Diagnostic Imaging Centers to deploy IntelePACS Breast Imaging digital mammography solution

FDA grants priority review status to Eisai's eribulin NDA

Prototype breast cancer vaccine shows promising results in mice

New report shows one in three young women receive HPV vaccine to prevent cervical cancer

Canada willing to spend $1B on G8 maternal, child health initiative

Amgen's Prolia receives FDA approval for treatment of postmenopausal women with osteoporosis

FDA approves Prolia for postmenopausal women with osteoporosis

Paid parental leave in Australia may soon be a reality

GE Healthcare introduces new CESM technology to aid in breast cancer diagnosis

Hepatitis C investigations intensify as number of women infected by doctor rises

Health law mandates higher Medicare payment for osteoporosis tests

New study finds usage of antidepressants increases risk of miscarriage in pregnant women

Women unaware of their heart disease risk: Report

Free educational forum tailored to the needs of people diagnosed with breast cancer

European Society of Human Reproduction and Embryology 2010 meeting set for June 27-30 in Rome, Italy

Overall increase of cesarean births not due to maternal request

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News